Financials data is unavailable for this security.
View more
Income statement information is not available for Life Science REIT PLC .
| Gross margin | 72.20% |
|---|---|
| Net profit margin | -145.80% |
| Operating margin | -109.71% |
| Return on assets | -7.89% |
|---|---|
| Return on equity | -12.26% |
| Return on investment | -9.80% |
More ▼
Cash flow in GBPView more
In 2025, cash reserves at Life Science REIT PLC fell by 31.27m. However, the company earned 7.62m from its operations for a Cash Flow Margin of 38.19%. In addition the company used 11.64m on investing activities and also paid 27.24m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.6659 |
|---|---|
| Tangible book value per share | 0.6659 |
More ▼
Balance sheet in GBPView more
| Current ratio | 0.076 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.5424 |
|---|---|
| Total debt/total capital | 0.3517 |
More ▼
Growth rates in GBP
Year on year, growth in earnings per share excluding extraordinary items increased 35.62%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 23.39 |
